| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:826.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Medicine (Y.D., M.H., T. Koizumi, K.F., T. Kobayashi, K.K.), Legal Medicine (M.O.), and Pharmacy (Y.K.), Shinshu University School of Medicine, Matsumoto, Japan.
Correspondence to Masayuki Hanaoka, MD, First Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail masayuki{at}hsp.md.shinshu-u.ac.jp
Background A defect of nitric oxide (NO) synthesis in the lung of high-altitude pulmonary edema (HAPE) has been suggested to contribute to its exaggerated pulmonary hypertension. Several polymorphisms have been identified in the gene encoding endothelial nitric oxide synthase (eNOS), which is a key enzyme responsible for NO synthesis, some of which were reported to be associated with vascular disorders.
Methods and Results We studied 41 HAPE-susceptible subjects (HAPE-s) and 51 healthy climbers (control group) in a Japanese population. We examined 2 polymorphisms of the eNOS gene, including the Glu298Asp variant and 27-base pair (bp) variable numbers of tandem repeats using polymerase chain reaction followed by restriction fragment length polymorphism. The Asp allelic frequency of the Glu298Asp variant was 25.6% in the HAPE-s and 9.8% in the controls, which was significantly different between the two groups (P=0.0044). The eNOS4a allelic frequency of 27-bp variable numbers of tandem repeats was 23.2% in the HAPE-s, significantly higher than that of 6.9% in the controls (P=0.0016). In HAPE-s group, 11 of 41 (26.8%) subjects possessed simultaneously both of the two significant alleles, but among the controls, none did, which showed a high statistical difference between the two groups (P=0.000059).
Conclusions Both polymorphisms of the eNOS gene were significantly associated with HAPE. A genetic background may underlie the impaired NO synthesis in the pulmonary circulation of HAPE-s. These polymorphisms could be genetic markers for predicting the susceptibility to HAPE.
Key Words: hypoxia hypertension, pulmonary genes nitric oxide synthase
This article has been cited by other articles:
![]() |
F. Sen, M. Demirturk, N. Abaci, E. Golcuk, H. Oflaz, A. Elitok, F. Kutluturk, H. Issever, N. E. Unaltuna, and N. C. Ozbey Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients Eur. J. Endocrinol., May 1, 2008; 158(5): 615 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bartsch and J. S. R. Gibbs Effect of Altitude on the Heart and the Lungs Circulation, November 6, 2007; 116(19): 2191 - 2202. [Full Text] [PDF] |
||||
![]() |
A. Ahsan, G. Mohd, T. Norboo, M. A. Baig, and M. A. Q. Pasha Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema. Chest, November 1, 2006; 130(5): 1511 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maggiorini High altitude-induced pulmonary oedema Cardiovasc Res, October 1, 2006; 72(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saxena, R. Kumar, T. Madan, V. Gupta, K. Muralidhar, and P. U. Sarma Association of Polymorphisms in Pulmonary Surfactant Protein A1 and A2 Genes With High-Altitude Pulmonary Edema Chest, September 1, 2005; 128(3): 1611 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson Physiological aspects of high-altitude pulmonary edema J Appl Physiol, March 1, 2005; 98(3): 1101 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, O. V. Evgenov, and F. Ichinose NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice J Appl Physiol, February 1, 2005; 98(2): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ahsan, R Charu, M A Q Pasha, T Norboo, F Afrin, and M A Baig eNOS allelic variants at the same locus associate with HAPE and adaptation Thorax, November 1, 2004; 59(11): 1000 - 1002. [Full Text] [PDF] |
||||
![]() |
H. A. Ghofrani, F. Reichenberger, M. G. Kohstall, E. H. Mrosek, T. Seeger, H. Olschewski, W. Seeger, and F. Grimminger Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Ann Intern Med, August 3, 2004; 141(3): 169 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M P Samuels The effects of flight and altitude Arch. Dis. Child., May 1, 2004; 89(5): 448 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y H Lee, H J Kim, Y H Rho, S J Choi, J D Ji, and G G Song Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis Lupus, March 1, 2004; 13(3): 188 - 191. [Abstract] [PDF] |
||||
![]() |
G. Paolo Rossi, M. Cesari, M. Zanchetta, S. Colonna, G. Maiolino, L. Pedon, M. Cavallin, P. Maiolino, and A. C. Pessina The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study J. Am. Coll. Cardiol., March 19, 2003; 41(6): 930 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Marian and E. Boerwinkle "Into Thin Air" and the Genetics of Complex Traits Circulation, August 13, 2002; 106(7): 768 - 769. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |